Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DIAMOND: Apixaban vs Aspirin after Aortic Bioprosthesis
NCT05687448Phase 3Not yet recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Sep 2025
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of apixaban in thromboembolism, sponsored by Assistance publique - Hôpitaux de Paris. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
apixaban
03
Conditions
thromboembolism
Beyond the preview
Go deeper on NCT05687448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05687448.